Repligen
RGEN
#2045
Rank
C$12.82 B
Marketcap
C$227.92
Share price
-0.47%
Change (1 day)
14.26%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): C$34.85 Million

According to Repligen 's latest financial reports the company's current earnings are C$0.70 Billion. In 2024 the company made an earning of -C$8.71 Million a decrease over its 2023 earnings that were of C$66.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$34.85 M-500.19%
2024 -C$8.71 Million-113.01%
2023 C$66.93 M-78.01%
2022 C$0.30 B33.37%
2021 C$0.22 B131.52%
2020 C$98.57 M101.31%
2019 C$48.96 M25.93%
2018 C$38.88 M105.61%
2017 C$18.91 M-11.46%
2016 C$21.35 M14.91%
2015 C$18.58 M20.26%
2014 C$15.45 M-51.49%
2013 C$31.86 M90.98%
2012 C$16.68 M
2010 C$0.24 M-103.81%
2009 -C$6.34 Million-223.84%
2008 C$5.11 M
2006 -C$3.44 Million229.64%
2005 -C$1.05 Million-89.16%
2004 -C$9.63 Million-16.86%
2003 -C$11.58 Million88.72%
2002 -C$6.14 Million-27.88%
2001 -C$8.51 Million-1.74%
2000 -C$8.66 Million85.93%
1999 -C$4.66 Million159.16%
1998 -C$1.8 Million85.71%
1997 -C$0.97 Million-70.83%
1996 -C$3.32 Million-72.41%
1995 -C$12.02 Million-60.63%
1994 -C$30.54 Million45.39%
1993 -C$21 Million39.45%
1992 -C$15.06 Million-32.3%
1991 -C$22.25 Million6.62%
1990 -C$20.87 Million1577.78%
1989 -C$1.25 Million-57.14%
1988 -C$2.91 Million-362.5%
1987 C$1.1 M-130.77%
1986 -C$3.6 Million136.36%
1985 -C$1.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
C$0.51 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.93 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.80 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$14.17 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$9.80 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.15 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-C$30.67 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA